Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 76
Titolo Data di pubblicazione Autore(i) File
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 1999 Caciagli B.; Carotti S.; Morganti M.; Landini I.; Nobili S.; Mazzei T.; Toffoli G.; Mini E
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 1999 Caciagli B.; Carotti S.; Morganti M.; Landini I.; Nobili S.; Mazzei T.; Toffoli G.; Mini E
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 2001 Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Jansen G, Peters GJ, Toffoli G, Priest DG, Mini E
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1. 2001 Mini E.; Caciagli B.; Carotti S.; Landini I.; Morganti M.; Nobili S.; Mazzei T.; Toffoli G.; Jansen G.; Peters G.J.; Priest D.J
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 2001 Carotti S.; Landini I.; Caciagli B.; Nobili S.; Mazzei T.; Mini E
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 2001 Mini E.; Caciagli B.; Carotti S.; Landini I.; Morganti M.; Nobili S.; Coronnello M.; Toffoli G.; Jansen G.; Peters G.J.; Priest D.G.; Mazzei T
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 2002 Mini E, Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Toffoli G, Jansen G, Peters GJ, Priest DG, Mazzei T
Sequence-dependent interactions between oxaliplatin (OHP) and 5-fluorouracil (5-FU) in human colon carcinoma cell lines 2002 Mazzei T.; Carotti S.; Landini I.; Caciagli B.; Nobili S.; Mini E
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 2003 Landini I; Carotti S; Caciagli B; Morganti M; Napoli C; Nobili S; Giglioni B; Boddi V; Mazzei T; Mini E
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 2003 Morganti M; Ciantelli M; Giglioni B; Nobili S.; Papi L.; Landini I.; Napoli C.; Valanzano R.; Cianchi F; Boddi V.; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 2004 Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E.
Molecular characterization of established human colorectal carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil (5-FU) by different selective schedules 2004 A. Tempestini; E. Witort; L. Papucci; N. Schiavone; M. Donnini; A. Lapucci; F. Perna; M. Morganti; B. Caciagli; I. Landini; A. Sobrero; E. Mini; S. Capaccioli
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 2004 Morganti M, Ciantelli M, Giglioni B, Putignano AL, Nobili S, Papi L, Landini I, Napoli C, Valanzano R, Cianchi F, Boddi V, Tonelli F, Cortesini C, Mazzei T, Genuardi M, Mini E
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. 2005 R. Ottanà; S. Carotti; R. Maccari; I. Landini; G. Chiricosta; B. Caciagli; MG Vigorita; E. Mini
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 2005 Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Cellular pharmacology of gemcitabine. 2006 E. Mini; S. Nobili; B. Caciagli; I. Landini; T. Mazzei
Pharmacological strategies for overcoming multidrug resistance. 2006 S. Nobili; I. Landini; B. Giglioni; E. Mini
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 2008 Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 2008 Napoli C, Nobili S, Morganti M, Landini I, Cianchi F, Valanzano R, Tonelli F, Mazzei T, Mini E
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 2008 Luceri C, Castagnini C, Bigagli E, Toti S, Landini I, Napoli C, Nobili S, Mini E, Dolara P
Mostrati risultati da 1 a 20 di 76
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile